Study supports early use of antifungal therapy in NICU babies

04/6/2012 | Medscape (free registration)

Empiric antifungal therapy should be considered before blood culture results are available for extremely low birth weight babies at high risk of invasive Candida to help prevent death or neurodevelopmental impairment, researchers reported in The Journal of Pediatrics. Duke University researchers said Candida species are a leading cause of death in NICUs and waiting for blood culture results could take days and have fatal consequences.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI